Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.
Radiodermatitis, Injury, Radiation
About this trial
This is an interventional prevention trial for Radiodermatitis focused on measuring barrier film, spray skin protection, liquid-film, barrier product
Eligibility Criteria
Inclusion Criteria: patients with anal and rectal cancer with indication for radiotherapy and conventional fractionation of treatment in a linear accelerator; age > or = 18 years; no previous history of radiotherapy in the same field/site of treatment (reirradiation).
-
Exclusion Criteria:patients with pre-existing irradiated dermatitis, which makes skin assessment difficult; previous report of allergic reaction to any of the products used in the research.
-
Sites / Locations
- INCA Research Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group Experimental
Group control
Participants who will use the spray skin protector
Participants who will use moisturizer Dnativ Revita Derm.